For instance, the induction of ICD by anthracycline-based chemotherapies and radiotherapy relies heavily on their capacity to activate IFN-dependent gene expression programs within tumor cells, thereby facilitating the generation of robust antitumor immune responses (180, 181). This evidence concerns the gene IFNA1 and neoplasm.